PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.08%
Revenue growth under 50% of MRVL's 22.86%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
12.14%
Gross profit growth under 50% of MRVL's 33.65%. Michael Burry would be concerned about a severe competitive disadvantage.
15.73%
EBIT growth below 50% of MRVL's 161.81%. Michael Burry would suspect deeper competitive or cost structure issues.
16.53%
Operating income growth under 50% of MRVL's 161.81%. Michael Burry would be concerned about deeper cost or sales issues.
16.87%
Net income growth under 50% of MRVL's 152.48%. Michael Burry would suspect the firm is falling well behind a key competitor.
18.87%
EPS growth under 50% of MRVL's 150.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
19.23%
Diluted EPS growth under 50% of MRVL's 150.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-2.03%
Share reduction while MRVL is at 0.36%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.01%
Reduced diluted shares while MRVL is at 4.76%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.70%
Dividend growth of 0.70% while MRVL is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-20.85%
Negative OCF growth while MRVL is at 26.16%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-43.18%
Negative FCF growth while MRVL is at 33.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
74.35%
10Y revenue/share CAGR under 50% of MRVL's 604.34%. Michael Burry would suspect a lasting competitive disadvantage.
45.91%
5Y revenue/share CAGR at 50-75% of MRVL's 85.87%. Martin Whitman would worry about a lagging mid-term growth trajectory.
21.46%
3Y revenue/share CAGR above 1.5x MRVL's 5.36%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
24.50%
10Y OCF/share CAGR under 50% of MRVL's 2360.00%. Michael Burry would worry about a persistent underperformance in cash creation.
-8.14%
Negative 5Y OCF/share CAGR while MRVL is at 195.77%. Joel Greenblatt would question the firm’s operational model or cost structure.
-25.55%
Negative 3Y OCF/share CAGR while MRVL stands at 2.26%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-15.87%
Negative 10Y net income/share CAGR while MRVL is at 3216.06%. Joel Greenblatt sees a major red flag in long-term profit erosion.
65.53%
5Y net income/share CAGR at 75-90% of MRVL's 76.18%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
49.96%
3Y net income/share CAGR above 1.5x MRVL's 23.04%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
9.16%
Below 50% of MRVL's 911.39%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
15.04%
Below 50% of MRVL's 44.60%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
0.96%
Below 50% of MRVL's 11.68%. Michael Burry suspects a serious short-term disadvantage in building book value.
513.01%
Dividend/share CAGR of 513.01% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
384.68%
Dividend/share CAGR of 384.68% while MRVL is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
52.06%
3Y dividend/share CAGR of 52.06% while MRVL is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
12.39%
AR growth well above MRVL's 15.10%. Michael Burry fears inflated revenue or higher default risk in the near future.
5.72%
Inventory growth well above MRVL's 3.83%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-1.67%
Negative asset growth while MRVL invests at 4.51%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.55%
50-75% of MRVL's 2.61%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
5.95%
We increase R&D while MRVL cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
5.29%
We expand SG&A while MRVL cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.